Skip to content

Clinical trials

Observational Genetic Diseases, Inborn trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Observational Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20131
20142
20171
20194
20211
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting5
Unknown status4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Maastricht University Medical Center3
Erasmus Medical Center2
Editas Medicine, Inc.1
Friedreich's Ataxia Research Alliance1
JCR Pharmaceuticals Co., Ltd.1
Leiden University Medical Center1
Novo Nordisk A/S1
REGENXBIO Inc.1
Rocket Pharmaceuticals Inc.1
The Netherlands Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn15
Cardiovascular Diseases3
Arrhythmias, Cardiac2
Carbohydrate Metabolism, Inborn Errors2
Cardiomyopathies2
Congenital Abnormalities2
Death, Sudden, Cardiac2
Rare Diseases2
Arrhythmogenic Right Ventricular Dysplasia1
Ataxia1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.